What are the key barriers and emerging opportunities in this market?
Barriers include misdiagnosis or underdiagnosis of celiac disease, lack of specific approved drug therapies (many treatments are still in trials), and reliance on dietary management. Opportunities are driven by the pipeline of novel medical therapies (e.g. tight-junction modulators, enzyme-based therapies), increasing patient awareness, and regulatory & government support for orphan and autoimmune disease treatments.
https://www.marketresearchfutu....re.com/reports/celia
Like
Comment
Share
